|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
11 October 2021 |
|
Main ID: |
NCT03048435 |
|
Date of registration:
|
07/02/2017 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Cervical Ca PROs in Clinical Practice
|
|
Scientific title:
|
Feasibility and Acceptability of Measuring Cervical Cancer Specific Patient-Reported Outcomes in Clinical Practice |
|
Date of first enrolment:
|
February 27, 2017 |
|
Target sample size:
|
100 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT03048435 |
|
Study type:
|
Observational |
|
Study design:
|
|
|
Phase:
|
|
|
|
Countries of recruitment
|
|
Canada
| | | | | | | |
|
Contacts
|
|
Name:
|
Jennifer Croke, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
University Health Network--Princess Margaret Cancer Centre |
| | |
|
Key inclusion & exclusion criteria
|
Patient Inclusion Criteria:
1. Adult (> 18 years) English speaking patients
2. Treated with curative intent with chemo-radiotherapy
3. Seen in routine clinic follow-up within 5 years post completion of treatment
Patient Exclusion Criteria:
1. Patients at their anticipated last clinic visit prior to cancer center discharge
2. Patients unable to complete the EORTC QLQ CX-24 questionnaire due to inability to read
or write.
3. Non-English speaking patients
4. Patients of the principal investigator. The rationale for this is that patients of the
principal investigator who complete the Feedback form may be biased and this may be
reflected in the results.
Oncologist Inclusion Criteria:
1. Oncologists who treat cervix cancer
2. Oncologists with at least one consenting patient enrolled in the study
Oncologist Exclusion Criteria:
1) Principal investigator listed on the protocol. The rationale for this is that
oncologists who are also investigators on this study may have inherent bias in the study
which may be reflected in the results of the Feedback form.
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Cervical Cancer
|
|
Radiation Therapy
|
|
Intervention(s)
|
|
Other: Physician Feedback Form
|
|
Other: EORTC QLQ CX-24
|
|
Primary Outcome(s)
|
|
Percentage of favorable scores (Agree or strongly agree) on Feedback Form
[Time Frame: 9 months]
|
|
Percentage of EORTC QLQ CX24 questionnaire completed
[Time Frame: 9 months]
|
|
Secondary ID(s)
|
|
OCREB 16-055
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|